PeptideStack
5.2kquestions
20kanswers
220users

Why do two papers on PIONEER-1 report different headline figures?

Asked 12 Jan 2025Modified 19 months agoViewed 33k times
33

My laboratory results are from the same laboratory each time, drawn fasting, which I gather matters.

I want to know whether this is a real physical effect or an artefact of how it is measured.

What prompted the question is an inconsistency between two sources I otherwise trust.

What is the causal chain, and where does it stop being established?

clinical-trials
clinical-trials

Reading the primary literature properly: estimands, intention-to-treat versus per-protocol, confidence intervals, absolute versus relative…

745 questions
dosing-math
dosing-math

The arithmetic itself: milligrams to millilitres to insulin units, concentration after reconstitution, dose per draw, and vial-days per vial. Show…

764 questions
semaglutide
semaglutide

A GLP-1 receptor agonist with a fatty-acid-acylated backbone and a roughly one-week half-life, marketed for type 2 diabetes and for weight…

470 questions
shareeditfollowflag
NA
askednoor_alhassan11k2712 Jan 2025
7Is that the primary endpoint or a secondary one? They get quoted interchangeably. – Dr_Jonas_Halvorsen 3 months ago
6Do you have the population it was measured in? The figure moves a lot between them. – rune_thoresen 2 months ago
add a comment

No answers yet

This question has not been answered. It has been viewed 33k times, which suggests the question is of interest and the answer is not obvious. If you can answer it with a source or a worked calculation, it will be read. See how to ask and answer.
Sponsored

Sigma-Aldrich - Certified Reference Materials

Analytical standards and reagents with traceable certificates. Every quantitative result you read inherits the accuracy of the standard behind it.

Shop standards

Your answer

Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.

Not medical advice. Research-use-only compounds are not approved for human use.